Oren Gilad

Insider Reports History

Entity
Individual
Location
535 Boylston Street, Boston, MA
Signature
/s/ John P. Hamill, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Oren Gilad:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aprea Therapeutics, Inc. President/CEO, Director Common Stock 333K $1.31M $3.92 Oct 23, 2024 Direct
Aprea Therapeutics, Inc. President/CEO, Director Common Stock 1.2K $4.7K $3.92 Oct 23, 2024 By Daughter
Aprea Therapeutics, Inc. President/CEO, Director Common Stock 600 $2.35K $3.92 Oct 23, 2024 By Son
Aprea Therapeutics, Inc. President/CEO, Director Stock Options (Right to Buy) 26.9K Mar 28, 2024 Direct
Aprea Therapeutics, Inc. President/CEO, Director Tranche A Warrant 1K Mar 13, 2024 Direct
Aprea Therapeutics, Inc. President/CEO, Director Tranche B Warrant 1K Mar 13, 2024 Direct

Insider Reports Filed by Oren Gilad

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APRE Aprea Therapeutics, Inc. Oct 23, 2024 1 $1.96K 4 Oct 24, 2024 President/CEO, Director
APRE Aprea Therapeutics, Inc. Oct 15, 2024 1 $725 4 Oct 16, 2024 President/CEO, Director
APRE Aprea Therapeutics, Inc. Oct 10, 2024 2 $2.97K 4 Oct 15, 2024 President/CEO, Director
APRE Aprea Therapeutics, Inc. Mar 28, 2024 2 $0 4 Mar 28, 2024 President, CEO, Director
APRE Aprea Therapeutics, Inc. Mar 13, 2024 3 $14.6K 4 Mar 14, 2024 President, CEO, Director
APRE Aprea Therapeutics, Inc. Aug 23, 2022 4 $0 4 Mar 13, 2023 President, CEO, Director
APRE Aprea Therapeutics, Inc. Jul 28, 2022 2 $0 4 Aug 1, 2022 President, CEO
APRE Aprea Therapeutics, Inc. May 16, 2022 0 $0 3 May 26, 2022 President, Director